What's new

Human medicines European public assessment report (EPAR): Dupixent, dupilumab, Date of authorisation: 26/09/2017, Revision: 39, Status: Authorised

Human medicines European public assessment report (EPAR): Dupixent, dupilumab, Date of authorisation: 26/09/2017, Revision: 39, Status: Authorised

Feb 14, 2025 - 11:30
 0
Human medicines European public assessment report (EPAR): Dupixent, dupilumab, Date of authorisation: 26/09/2017, Revision: 39, Status: Authorised
Human medicines European public assessment report (EPAR): Dupixent, dupilumab, Date of authorisation: 26/09/2017, Revision: 39, Status: Authorised
Read More

Tags:

Previous Article

Monsoon lands at London Gatwick

Next Article

Perfume with perfumers: Is AI a threat to the human nose?

Related Posts

Medical devices

Medical devices

Feb 10, 2025  0

Human medicines European public assessment report (EPAR): Copalia, amlodipine,valsartan, Date of authorisation: 15/01/2007, Revision: 32, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 12, 2025  0

EMEA-003522-PIP01-23

EMEA-003522-PIP01-23

Apr 1, 2025  0